Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HKP201
- Development stage
- Preclinical
- Lead developer
- Hankook Korus Pharm
- Administration
- Topical
01
Overview
HKP201 is a natural medicine product being developed by Hankook Korus Pharm for the treatment of psoriasis. It is a topical cream formulation containing a 2% w/w extract of *Artemisia capillaris*. In preclinical studies using imiquimod-induced psoriasis mouse models, HKP201 demonstrated antipsoriatic properties by reducing cumulative scores for redness, thickness, and scaling, as well as reducing epidermal thickness. The specific biological target and detailed mechanism of action have not been disclosed, but the drug represents a traditional herbal medicine approach to treating inflammatory skin diseases.
- Other names
- ArtemisiaArtemisia capillaris extract
Beyond the preview
Go deeper on HKP201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HKP201.